164 related articles for article (PubMed ID: 31409895)
21. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
22. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation.
Martinez NM; Agosto L; Qiu J; Mallory MJ; Gazzara MR; Barash Y; Fu XD; Lynch KW
Genes Dev; 2015 Oct; 29(19):2054-66. PubMed ID: 26443849
[TBL] [Abstract][Full Text] [Related]
23. Identification of spliceosome components pivotal to breast cancer survival.
An J; Luo Z; An W; Cao D; Ma J; Liu Z
RNA Biol; 2021 Jun; 18(6):833-842. PubMed ID: 32965163
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
25. PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.
Zheng YZ; Xue MZ; Shen HJ; Li XG; Ma D; Gong Y; Liu YR; Qiao F; Xie HY; Lian B; Sun WL; Zhao HY; Yao L; Zuo WJ; Li DQ; Wang P; Hu X; Shao ZM
Cancer Res; 2018 Jun; 78(12):3190-3206. PubMed ID: 29700004
[TBL] [Abstract][Full Text] [Related]
26. Histone and RNA-binding protein interaction creates crosstalk network for regulation of alternative splicing.
Kim YE; Park C; Kim KE; Kim KK
Biochem Biophys Res Commun; 2018 Apr; 499(1):30-36. PubMed ID: 29551686
[TBL] [Abstract][Full Text] [Related]
27. Activation-Dependent TRAF3 Exon 8 Alternative Splicing Is Controlled by CELF2 and hnRNP C Binding to an Upstream Intronic Element.
Schultz AS; Preussner M; Bunse M; Karni R; Heyd F
Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28031331
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
[TBL] [Abstract][Full Text] [Related]
29. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
Dvinge H; Guenthoer J; Porter PL; Bradley RK
Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
[TBL] [Abstract][Full Text] [Related]
30. CELF RNA binding proteins promote axon regeneration in C. elegans and mammals through alternative splicing of Syntaxins.
Chen L; Liu Z; Zhou B; Wei C; Zhou Y; Rosenfeld MG; Fu XD; Chisholm AD; Jin Y
Elife; 2016 Jun; 5():. PubMed ID: 27253061
[TBL] [Abstract][Full Text] [Related]
31. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of the HOXA gene cluster in breast cancer.
Novak P; Jensen T; Oshiro MM; Wozniak RJ; Nouzova M; Watts GS; Klimecki WT; Kim C; Futscher BW
Cancer Res; 2006 Nov; 66(22):10664-70. PubMed ID: 17090521
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
36. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD; Herman-Sanchez N; Fuentes-Fayos AC; Lopez-Canovas JL; Luque RM
Endocr Relat Cancer; 2022 Sep; 29(9):R123-R142. PubMed ID: 35728261
[TBL] [Abstract][Full Text] [Related]
38. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
39. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes.
Gazzara MR; Mallory MJ; Roytenberg R; Lindberg JP; Jha A; Lynch KW; Barash Y
Genome Res; 2017 Aug; 27(8):1360-1370. PubMed ID: 28512194
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
